Analytical approaches to the study of the disposition of myelotoxic agents. by Rickert, D E et al.
Environmental Health Perspectives
Vol. 39, pp. 5-10, 1981
Analytical Approaches to the Study of
the Disposition of Myelotoxic Agents
by Douglas E. Rickert,* Terrie S. Baker,* and John P.
Chism*
Acorrelation ofmyelotoxic effect with concentration or a foreign compound ofits metabolite
at the site of action may provide useful insights into the mechanism of toxic action and/or its
amelioration. This correlation requires sensitive and specific assay methods. This communica-
tion describes useful methods for the study of benzene disposition in rodents. The assays are
sensitive, specific, and rapid. They rely on gas chromatography-mass spectrometry and on high
performance liquid chromatography. These methods have allowed measurement of catechol,
phenol, and hydroquinone in samples of rodent bone marrow following inhalation exposure to
benzene. Their application to the study of benzene metabolism in rat bone marrow in situ is
also described.
Introduction
The study of myelotoxicity, like the study of
other forms toxicity, requires a thorough knowl-
edge of the disposition of the toxicant under inves-
tigation. The ultimate goal is the identification of
the proximal toxicant and a description of the
interactions of that toxicant with cellular constitu-
ents of the target issue. Properly designed disposi-
tion studies can yield useful information on the
structure and concentration of putative proximal
toxicants at the site of action. In this respect,
disposition studies ofmyelotoxic agents are similar
to disposition studies of any other type of toxic
agent.
Analysis for myelotoxic agents and their metabo-
lites in the target tissue does, however, present
some interesting problems. The scarcity of bone
marrow tissue in rodents requires extremely efficient
and sensitive methods for analysis. The studies
described here were done with benzene. In addition
to problems associated with sampling and analysis
ofsmall amounts oftissue, benzene and its metabo-
lites pose analytical problems because of their
volatility, instability, and/or highly polar nature.
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Successful circumvention ofsome oftheseproblems
has been accomplished with combined gas chro-
matography-mass spectrometry and high perfor-
mance liquid chromatography. We have used these
techniques to describe the pharmacokinetics of
benzene after inhalation exposure in rats (1) to
demonstrate that bone marrow has metabolic activ-
ity toward benzene (2), and to begin to correlate
benzene metabolism in vitro with alterations in in
vivo benzene toxicity produced by pretreatment
with other foreign compounds (3).
Methods and Results
Male, Fischer-344 rats (200-250 g) were exposed
to 500 ppm benzene in a 1100 liter dynamic air flow
chamber for 6 hr. The time required for benzene
concentration to reach 99% ofthe target concentra-
tion was 20.3 min. At the end of the exposure
period the animals were removed. Groups of three
were sacrificed by decapitation 0.5, 1, 1.5, 2, 2.5, 3,
4, 6, and 9 hr after removal. Heparinized blood,
perirenal fat, and bone marrow were analyzed for
benzene. The goals in developing a method for
benzene inthese tissues included sufficient sensitiv-
ity to measure benzene in bone marrow, specificity
sufficient to ensure that endogenous compounds did
not interfere with the measurement, and a minimi-
5zation ofsample preparation so that the volatility of
benzene would not lead to erroneously low values.
In order to correct for the volatility of benzene,
deuterated (d6) benzene (Merck and Co., Inc.,
Quebec, Canada) was added as an internal standard
immediately after removal ofthe tissues. Methanol
(0.1 ml) containing 1 ,ugbenzene-d6/ml was added to
0.1 ml blood. A 15 to 25 mg portion ofbone marrow
was mixed with 0.1 ml methanol containing 1 ,ug
benzene-d6/ml. All other tissues were homogenized
on ice in 3 ml methanol (containing 1 ,ug benzene-
d6Iml)/g of wet weight tissue. All samples were
sonicated and mixed then centrifuged at 1500g for
15 min. Then 1-5 ,il of the supernate was injected
onto the gas chromatograph-mass spectrometer
(Finnegan4021, Finnegan Corp., Sunnyvale, Calif.).
The mass spectrometer was operated in the se-
lected ion monitoring mode and alternately focused
on m/e 78 (parent ion ofbenzene) and mle84 (parent
ion of benzene-d6). Reconstructed mass chromato-
grams ofa typical standard are shown in Figure 1.
The gas chromatography column was Tenax GC
(Suppleco, Inc., Bellafonte, Pa.) packed in a 2 m x
2 mm (i.d.) glass column. Helium carrier gas was
admitted to the column at 20 ml/min. The column
was temperature programmed from 190 to 225°C at
a rate of24°C/min. The ratio ofthe area under the
peak at mle 78 to the area under the peak at mle 84
was plotted against the concentration ofbenzene in
the standards (Fig. 2). The standard curve was
linear over final benzene concentrations of 100
ng/ml to 100 jig/ml. Thus, the method allowed
quantitation of benzene at concentrations between
200 ng/ml and 200 ,uag/ml in blood, between 200 ng/g
and 200 ,ug/g in bone marrow (if volumes injected
onto gas chromatography-mass spectrometer were
increased to 5 [lI), and between 400 ng/g and 400
,ug/g in other tissues. Disappearance of benzene
from blood, bone marrow, and perirenal fat is
shown in Figure 3.
Three metabolites of benzene, phenol, catechol,
and hydroquinone, were measured in blood and
bone marrow from the above rats. A 5-ml portion of
methanol was added to 1.0 ml blood or 15-25 mg
bone marrow. Methanol (0.1 ml) containing 1.0 jig
phenol-d6/ml (Merck & Co., Quebec, Canada) was
added to the mixture which was then mixed
vigorously and centrifuged at 1500g for 15 min. The
supernate was transfered to a clean tube and 0.1 ml
of0.1M KOH was added. The samples were evapo-
rated to dryness undera stream ofN2. Trifluoroacetic
anhydride(Aldrich ChemicalCo., Milwaukee, Wisc.)
(500-100 ,ul) was added, and aliquots of 1-2 Rl were
injected onto the gas chromatograph-mass spec-
trometer. The resulting trifluoroacetate derivatives
were separated on a 2 m x 2.0 mm i.d. glass column
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FIGURE 1. Ion chromatograms of benzene and benzene-d6:
(top) chromatogram for benzene, mle 78 was monitored;
(middle) chromatogram of benzene-d6 for which mle 84 was
monitored; (bottom) sum of the other two chromatograms.
Numbers above the peaks are, from top to bottom, scan
number, height, and area.
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FIGURE 2. Typical standard curve for benzene plotted on a
log-log scale.
packed with 3% OV-1 on Chromasorb W (Supelco,
Inc., Bellefonte, Pa.) and held at 90°C. The carrier
gas was helium at a flow rate of20 ml/min. The ions
monitored by the mass spectrometer were tile 195,
the parent ion for fluoroacetylated phenol-d5 (one
deuterium atom is lost in the derivatization reac-
tion); mle 190, the parent ion for fluoroacetylated
phenolandmle302, theparentionforfluoroacetylated
catechol and hydroquinone. A typical mass chroma-
togram for a standard mixture is shown in Figure 4.
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FIGURE 3. Disappearance ofbenzene from blood, bone marrow, and adipose tissue following 6 hr exposure
to 500 ppm benzene in air.
A standard curve was prepared by carrying 500 pg
to 10 ng of phenol, catechol, or hydroquinone
through the above procedure. A standard curve is
given in Figure 5. Sensitivities were 50 ng of
metabolite/gbone marrow or500 pgofmetabolite/ml
blood. Concentrations of phenol, catechol, and hy-
droquinone at several times following the end of
exposure and given in Table 1.
Both normal-phase and reversed-phase high per-
formance liquid chromatography have been suc-
cessfully applied to studies of benzene metabolism.
There is evidence in the literature that rat bone
marrowismetabolicallycompetenttowardxenobiotics
(4), but there has only recently been a demonstra-
tion ofbone marrow's ability to metabolize benzene
in situ (2). Because certain benzene metabolites,
namely, sulfate and glucuronide conjugates, are not
readily analyzed by combined gas chromatography-
mass spectrometry, we employed normal-phase
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FIGURE 4. Ion chromatograms of (top) fluoroacetylated phe-
nol, (middle) phenol-d5, (bottom, first peak) catechol and
(bottom, second peak) hydroquinone. Numbers above peaks
as in Figure 1.
Table 1. Concentration of phenol, catechol, and hydroquinone in rat blood and bone marrow after a 6 hr exposure to 500 ppm
benzene in air.
Phenola Catechola Hydroquinonea
Time from end Bone Bone Bone
of exposure, hr Blood, ng/ml marrow, ng/g Blood, ng/ml marrow, ng/g Blood, ng/ml marrow, ng/g
0.5 1958 ± 540 6101 ± 1500 53 ± 23 7215 + 704 18 ± 8 58480 ± 3037
1.0 1108 + 236 2808 + 1600 14 + 6 5097 + 1586 59 + 11 15010 ± 4320
1.5 1431 + 521 19410 ± 9517 30 ± 12 6982 ± 3633 50 + 20 19150 ± 1070
2.0 444 ± 64 ND 59 + 10 5033 ± 1027 89 ± 20 14030 ± 2790
2.5 292 ± 35 ND 72 ± 10 3476 ± 266 253 ± 100 9545 ± 811
3.0 243 ± 61 1918 ± 1565 61 ± 30 7223 ± 1725 68 ± 9 26630 ± 5911
4.0 197 ± 76 894 ± 730 ND 5393 + 1115 102 ± 35 42200 ± 18130
6.0 62± 25 ND 37 12 2614 850 52± 20 7050± 2150
9.0 ND ND 19 ± 12 13160 ± 4036 66 ± 30 35390 ± 1042
aValues are means of 3-6 rats + S.E.M.
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FIGURE 5. Typical standard curves for phenol, catechol, and
hydroquinone.
high performance liquid chromatography. Male,
Fischer-344 rats were aesthetized with an ani-
leridine-ketamine mixture; the left common iliac
vein and artery were cannulated and the isolated
hind limb was perfused with citrated, oxygenated
rat blood at a flow of 1 ml/min. Between 0.5 and 2.0
mCi of14C-benzene (39 mCi/mmole) was introduced
directly into the marrow via a hole drilled at the
distal end ofthe femur. Bone wax was used to close
the hole, and blood was collected from the iliac vein
for 1 hr in 10-min fractions. The bone marrow was
removed at the end ofthe hour perfusion, and blood
and bone marrow were analyzed for benzene me-
tabolites. Blood (10 ml) or bone marrow (15-25 mg)
homogenized in 1.0 ml phosphate buffer, pH 7.4,
was mixed with 50 pug each phenol, catechol,
hydroquinone, and 1,2,4-benzenetriol. The pH was
adjusted to 1.0 with l.OM HCl, and the mixture
was extracted three times with two volumes of
ethyl acetate. The ethyl acetate layers were com-
8
bined, dried over anhydrous magnesium sulfate,
and filtered. After evaporation under a stream of
N2 to a final volume of about 1.0 ml, the ethyl
acetate fractions were passed over a short silica gel
column (Waters Associates, Milford, Mass.). The
sample was then further concentrated to
- 20 [lI
and then injected onto the high-pressure liquid
chromatograph (WatersAssociates, Milford, Mass.).
Separation was accomplished with two DuPont
Zorbax silica columns. The flow was programmed
from 0.8 ml/min to 1.6 ml/min over 20 min. The
solvent system used was 74.9% methylene chloride,
25% ethyl acetate, 0.1% methanol, with 100 [lI of
88% formic acid added per 100 ml solvent. A typical
elution profile is shown in Figure 6. Radioactivity
co-eluted with phenol, catechol and hydroquinone.
Concentrations of these compounds in blood and
bone marrow from in situ perfusions are given in
Table 2.
The normal-phase separation ofbenzene metabo-
lites was satisfactory, but the time-consuming and
complicated sample preparation limited its utility in
more extensive studies with more samples and
lower amounts of radioactivity. We have now
developed a reversed-phase high-performance liq-
uid chromatographic procedure which allows sam-
ples to be injected in aqueous systems, thereby
reducing sample handling and shortening analysis
time. Trichloroacetic acid (125 pIu, 15% wlv) was
added to an incubation mixture (0.9 ml). The
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FIGURE 6. Normal-phase high pressure liquid chromatogram
of benzene metabolites. See text for conditions.
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uiTable 2. Concentrations ofphenol, catechol, and hydroquinone in venous blood ofisolated hind limb perfusion after injection of
benzene into bone marrow in situ.
Collection period, min Phenol, pmole/10 mina Catechol, pmole/10 mina Hydroquinone, pmole/10 mina
0-10 4540 773 222 74 93 7
10-20 664 151 59±22 11 ±5
20-30 247 41 184 117 4 3
30-40 221 29 49±20 11 8
40-50 192 123 68 27 12 10
50-60 59 28 21 9 11 7
aValues are means for 3-4 preparations ± S.E.M.
resulting mixture was centrifuged at 2000g for 5
min, and 100-200 ,ul of the supernate was injected
onto the high-pressure liquid chromatograph. The
column used was octadecylsilane (Waters Radial
Pak A) or octylsilane (Merck RP-8). Compounds
were eluted in 20 min by a linear gradient from
100% water containing 100 ,ul formic acid/l. to 100%
methanol containing 100 RI formic acid/l. A typical
elution profile of benzene metabolites is shown in
Figure 7.
A first application of the new analytical proce-
dure has been the study of benzene metabolism in
vitro by various tissues. When hepatic 10,OOOg
supernate was incubated in the presence of 14C-
benzene and an NADPH regenerating system, two
metabolite peaks appeared in the high performance
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FIGURE 7. Reversed-phase high pressureliquidchromatogram
of benzene metabolites. See text for conditions.
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liquid chromatogram. These peaks co-eluted with
hydroquinone and phenol. When the same incuba-
tion was repeated with the addition ofATP, sodium
sulfate, and uridine diphosphoglucuronic acid, the
peaks co-eluting with hydroquinone and phenol
decreased in size. An early-eluting peak, presuma-
bly a conjugate, appeared. Work to characterize
fully the metabolites formed from benzene in vitro
is continuing.
Discussion
Several methods for studying the disposition of
benzene have been described. Each has its particu-
lar advantages and disadvantages, and each could
be modified to study the disposition of other
myelotoxic agents as well. The mass spectrometric
methods described have the disadvantage ofrequir-
ing expensive equipment and trained operators,
but their sensitivity, specificity and simplicity of
sample preparation make them very attractive.
Using these methods we were able to show that
half-lives for bezene in all tissues studied (except
perirenal fat) were similar and that benzene is
concentrated in bone marrow and fat as well as in
organs of metabolism and excretion, the liver and
kidney. In addition, concentration of phenol in
blood and bone marrow declined rapidly after
termination of exposure, but catechol and hydro-
quinone did not. This suggests a possibility of
accumulation of these two potentially myelotoxic
metabolites.
While our gas chromatographic-mass spectrometric
methods required that we decide in advance which
compounds to quantitate, no such requirement was
imposed by the high performance liquid chromato-
graphic procedures employing radiolabelled ben-
zene. These techniques allowed us to demonstrate
the metabolism ofbenzene by bone marrow in situ
and to study the in vitro metabolism of benzene,
including conjugate formation.
As this publication is intended to be a description
of methods available for the study of xenobiotic
disposition, only briefexamples ofthe data obtained
9have been given. A fuller presentation and discus-
sion ofthe disposition data can be found in the cited
publications.
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